Abstract
Purpose:
Urogenital tuberculosis (UGT) is rarely reported in developed countries. This study evaluated the genetic susceptibility of Korean patients to UGT.
Materials and Methods:
A total of 35 UGT patients who were confirmed pathologically, 44 intrapulmonary tuberculosis (IPT) patients who were confirmed radiologically, and 102 controls over a 6 year period were enrolled in this study. The region of rs2243268 in interleukin-4 (IL-4) gene was amplified from whole blood samples, and the DNA sequences were read using the Sanger method.
Results:
Twenty women and 15 men were diagnosed with UGT. The occurrence of the CC, AC, and AA genotypes of rs2243268 were 26 (74.3%), 8 (22.9%), and 1 (2.9%), respectively, in UGT; 28 (63.6%), 15 (34.1%), and 1 (2.3%), respectively, in IPT; and 51 (50.0%), 45 (44.1%), and 6 (5.9%), respectively, in the control groups (p=0.115). The bivariate data of CC and AC/AA were 74.3% and 25.7% in UGT, 63.6% and 36.4% in IPT, and 50.0% and 50.0% in the control groups, respectively (p=0.029). The UGT was significantly different from the control group among the three genotypes (p=0.038, Fisher's exact test) and bivariate genotypes (p=0.017, Fisher's exact test). In addition, people carrying the CC genotype had a higher risk of UGT (odds ratios, 2.889; 95% confidence intervals, 1.233-6.770; p=0.015).
REFERENCES
1.Chernyaeva E., Rotkevich M., Krasheninnikova K., Yurchenko A., Vyazovaya A., Mokrousov I, et al. Whole-genome analysis of mycobacterium tuberculosis from patients with tuberculous spondylitis, Russia. Emerg Infect Dis. 2018. 24:579–83.
2.Turner RD., Chiu C., Churchyard GJ., Esmail H., Lewinsohn DM., Gandhi NR, et al. Tuberculosis infectiousness and host susceptibility. J Infect Dis. 2017. 216(suppl_6):S636–43.
3.Harries AD. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet. 1990. 335:387–90.
4.Chandrasekaran P., Saravanan N., Bethunaickan R., Tripathy S. Malnutrition: modulator of immune responses in tuberculosis. Front Immunol. 2017. 8:1316.
5.Cantwell MF., McKenna MT., McCray E., Onorato IM. Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status. Am J Respir Crit Care Med. 1998. 157:1016–20.
6.Figueiredo AA., Lucon AM. Urogenital tuberculosis: update and review of 8961 cases from the world literature. Rev Urol. 2008. 10:207–17.
7.Qi H., Sun L., Jin YQ., Shen C., Chu P., Wang SF, et al. rs2243268 and rs2243274 of interleukin-4 (IL-4) gene are associated with reduced risk for extrapulmonary and severe tuberculosis in Chinese Han children. Infect Genet Evol. 2014. 23:121–8.
8.Sivangala R., Ponnana M., Thada S., Joshi L., Ansari S., Hussain H, et al. Association of cytokine gene polymorphisms in patients with tuberculosis and their household contacts. Scand J Immunol. 2014. 79:197–205.
9.Chatterjee S., Talaat KR., van Seventer EE., Feng CG., Scott AL., Jedlicka A, et al. Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages. PLoS One. 2017. 12:e0179701.
10.Song J., Park H., Lee G. Contribution of genetic variation rs266882 to prostate-specific antigen levels in healthy controls with serum PSA below 2.0 ng/ml. Biochem Genet. 2013. 51:264–74.
11.Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2015. 78:47–55.
12.Peto HM., Pratt RH., Harrington TA., LoBue PA., Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis. 2009. 49:1350–7.
13.Pehme L., Hollo V., Rahu M., Altraja A. Tuberculosis during fundamental societal changes in Estonia with special reference to extrapulmonary manifestations. Chest. 2005. 127:1289–95.